A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies
Trial ID or NCT#
NCT06208878
Status
NOT RECRUITING
Purpose
This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies
Official Title
A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR T Cellular Therapies
Investigator(s)
Wen-Kai Weng, MD, PhD
Blood and marrow transplant specialist,
Blood and marrow transplant specialist,
Lymphoma specialist,
Medical oncologist,
Multiple myeloma specialist
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and, by courtesy, of Dermatology
Contact us to find out if this trial is right for you.
Contact
Vivian Leung
View on